Introduction 156
The contemporary spinal surgeon is becoming increasingly aware of spinal tumors: metastases 157 are the most common neoplasm of the spine and will present in greater numbers as the global 158 population ages. 1 Due to differences in local management protocols, the decision to undergo 159 surgery and choice of specific operations are likely to vary between geographic regions. 160
Published studies examining spinal metastases are largely limited to the experience of single 161 centers utilizing a variety of tumor classification systems and outcomes measures, making it 162 difficult to compare clinical practices.
2-10 As a consequence, the differences in regional variations 163 in the treatment of spinal metastases remain poorly documented. 164
The Global Spinal Tumour Study Group (GSTSG) maintains an international, 165 prospectively collected dataset on the surgical treatment of spinal metastases employing a 166 standardized classification system of surgical approaches and the EQ-5D health outcome 167 measure to describe functional outcomes.
2,11 Here, we describe the epidemiological 168 characteristics, surgical management, and outcomes of spinal metastatic disease in ten countries 169 throughout four different regions of the world to determine the variation in surgical trends over 170 time and region. 171
172

Material and Methods 173
Inclusion/Exclusion Criteria 174
Patients diagnosed with spinal metastases between March 1991 and September 2016 at twenty-175 two referral centers in ten countries throughout Asia (China, Korea and Japan), mainland Europe 176 (Belgium, Denmark, France, the Netherlands, Spain), the United Kingdom, and North America 177 (Canada and the United States) were recruited for entry into the Global Spine Tumour StudyGroup database. All patients underwent surgical intervention. Anonymized patient data was 179 entered into the database directly by practitioners. Patients who were unable to provide consent 180 for participation in research or had incomplete follow-up data (date of death or minimum two 181 year follow-up) were excluded from the database. Ethical regulatory approval was obtained at 182 each of the institutions contributing to the GSTSG database; all patients gave informed consent. 183
184
Variables 185
Clinical data collected included primary malignancy type, spinal levels involved, other sites of 186 metastases (both visceral and extraspinal bone metastases), surgical approach, extent of resection 187 performed, surgical details, quality of life at presentation as assessed by EQ-5D, Frankel score 188 and survival. The extent of resection was stratified according to whether debulking, intralesional 189 corpectomy, or complete vertebrectomy was performed. The STROBE reporting guideline has 190 been implemented in writing this manuscript. 191
192
Statistical Analysis 193
Descriptive statistical summary measures were used to assess relevant variables. Mean and 194 standard deviation were calculated for continuous variables while binary and categorical 195 variables were summarized by frequency and percentage. Kaplan-Meier survival estimators were 196 fitted and curves were constructed. Values lower than P=.05 were considered significant. Data 197 analysis was performed using Stata 13 software (StataCorp LLC, Texas USA). and other regions (figure 2). Asian centers diverged from prevailing trends with a higher 216 frequency of colonic, liver, and lung carcinoma metastases, and a lower frequency of breast, 217 prostate, melanoma metastases, and myeloma. Whereas regions outside of Asia reported liver 218 carcinoma metastases in less than 5% of cases, these metastases were seen in Asian centers in 219 13% of patients. Similarly, lung carcinoma metastases were found in over a quarter (28%) of 220
Asian referrals, despite rates ranging from 10 to 16% elsewhere. By contrast Asian centers had 221 markedly lower rates of breast carcinoma metastases (6%) as compared with other regions, 222 which reported 14-21% of referrals. This trend was also seen in myeloma where the rate in Asian 223 centers (3%) was less than half that seen in mainland Europe and North America ( Globally, the majority of surgery was performed via a posterior-only midline approach to 240 the spine. Isolated posterior approaches were employed in 77% (in North America) to 94 % of 241 cases (in Asia). Combined anterior-posterior approaches to the spine, and anterior-only 242 approaches, were the next most common, being employed less than 20% and 10% of the time 243 respectively. Preoperative endovascular tumor embolization was employed in 10-22% of cases 244 worldwide, and was performed in 9.6% of cases in the UK, 14.6% of cases in mainland Europe, 245
22.1% of cases in Asia, and 16.4% of cases in North America. 246 greater than 50% of the lesion resected. For most regions, more palliative and debulking 256 surgeries were performed, rather than complete corpectomies or en bloc resections. North 257
American centers departed from this global trend in that a larger proportion of more aggressive 258 resections were performed. In Asian centers piecemeal vertebrectomy was uncommon. As a 259 result, resections in Asia can be largely dichotomized into piecemeal procedures or en bloc 260 vertebrectomy, revealing a preference for en bloc resection when vertebrectomy was the 261
objective. 262
The mean case duration differed little between regions, ranging from 3.3 to 3.8 hours 263
globally. The distribution of case duration reveals that most cases were clustered around the 264 overall mean of 3.5 hours in Mainland European (3.3 hours) and North American (3.6 hours) 265 centers, but UK and Asian centers had a substantial proportion of cases that lasted longer than 266 six hours in duration (mean duration 3.7 and 3.8 hours respectively). 
Regional differences in frequency of tumor types 340
In this study, the first global comparison of the surgical treatment of spinal metastases, 341
we report wide variation in the frequency of metastatic tumor types between regions. The 342 asymmetries observed in different parts of the world largely reflect those of primary cancer 343 diagnoses in the respective regions. For example, the finding that Asian centers had higher 344 numbers of GI, liver, and lung carcinoma metastases, reflects the high frequency of these 345 primary cancers reported in Asia. Examining regional variations in the incidence of liver cancer 346 in particular: of the over 750,000 new diagnoses of liver cancer made per year, China alone 347 accounts for 50%. 12 In comparison to other regions, the incidence of liver cancer in China is 348 more than three times that in North America and ten times that in some European countries. 
352
This explanation however fails to account for certain regional variations seen in our 353 study. Although Asian centers report the single largest proportion of spinal metastases in any 354 region with lung cancer accounting for over a quarter of all spinal metastases, the incidence of 355 primary lung cancer diagnoses is actually lower in China than it is in the United States. 13, 14 This 356 unexpected finding may be in part due to early detection initiatives in the United States which 357 call for regular radiographic screening of high risk patients, resulting in diagnosis of 358 asymptomatic patients with isolated lung nodules before metastasis to distant sites can 359 occur. 15, 16, 17 It is also worth remembering that this study group represents only a subset of 360 patients with spinal metastases in that it is limited to those who have undergone surgery fortreatment of their metastatic disease. Consequently, it may be the case that the advent and 362 widespread availability of targeted therapies for lung cancer in the United States is resulting in 363 better medical control and fewer surgical referrals. 18 Taken together, these considerations 364 illustrate that there is no simple or straightforward explanation for the different rates of primary 365 tumors metastasizing to the spine. Rather the interplay between regional primary cancer rates, 366 cancer screening protocols enabling early detection prior to distant spread, and access to 367 advanced oncological therapies, probably contribute to produce the regional variations we report 368
here. 369 370
Survival analysis 371
Examining the results of our survival analysis with respect to the year of diagnosis reveals that it is more likely that the gains achieved in long-term survival reflect a combination of earlier 380 detection, 15,16 more efficacious adjuvant medical therapies, 19, 20, 21, 22 and a better understanding of 381 spinal metastatic disease leading to selection of patients better suited for surgery with a greater 382 potential for long term survival. 10 Changes in the medical management of lung cancer are likely 383 to be responsible for better survival in recent years (figure 10), and similar trends were seen intypically not considered candidates for surgery, so a focused analysis of surgically treated 408 patients may introduce a selection bias whereby study participants represent a subset of patients 409 with better prognosis than the population of patients with spinal metastases at large. The data in 410 this study was entirely self-reported, and as such is susceptible to reporting bias. This is 411 particularly true for the extent of resection, which was based on each individual surgeon's 412 estimation of the overall percentage of the lesion resected rather than objective radiological 413 criteria. The surgical practice of individual centers may vary, and inclusion of data from units 414 with a preference for more complete or aggressive surgery may bias the results. Lastly, the 415 prospective collection of data over the span of more than a decade means that data was collected 416 at different points in time. 417
418
Conclusions 419
In this first global comparison of the epidemiology, surgical approaches, and long-term survival 420 in patients undergoing surgery for treatment of spinal metastases we find substantial regional 421 variation in the composition of primary tumor types leading to spinal metastatic disease despite 422 uniformity in the preferred surgical approach, surgical objectives, and long-term survival. The 423 regional variation reported here should lend further support for global collaboration, as what is 424 considered a rare metastasis for some may be commonplace for others. On a local scale, this data 425 should prompt surgeons to seek out oncologists with particular expertise in managing the 426 metastases that present most frequently in their region. 427
The long-term survival data reported here reveals that patients with spinal metastases are 428 living longer. This improvement in long-term survival should prompt reconsideration of our 429 surgical decision-making processes. Many of the prognostic scoring algorithms that we employin patient selection for surgery were constructed on data gathered more than a decade prior. 431
Given the improved long-term survival we report from 2011-2015, surgeons should be wary of 432 using these prognostic scoring systems, which might exclude patients from surgery on the basis 433 of predictions calculated using old data. 434
Surgery for spinal metastases can improve pain, deformity, and neurological function. 24 It 435 is well recognized that multidisciplinary team discussion is paramount in formulating treatment 436 strategies that yield the best outcomes for patients. Patients with spinal metastases are now living 437 longer without any change in surgical management, suggesting that this enhanced survival is 438 largely due to advances in medical therapy and radiation techniques. Consequently, the survival 439 benefit reported here should be interpreted as further support for a collaborative approach 440 towards the management of spinal metastases relying on expertise in oncology, surgery, and 441 radiotherapy, to offer an integrated and personalized treatment for patients. 
